Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- 最新申報
- 2024/11/14
2024 年第 1 季持倉
持倉截至 2024/3/31，2024/5/15 申報。只含多頭部位，變化是跟 2023 年第 4 季比股數。
- 持股檔數
- 65
- 較 2023 年第 4 季 +21
- 總值
- $3.11 億
- 較 2023 年第 4 季 +$1.37 億 (+79.1%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| AXSMAxsome Therapeutics, Inc. | COM | 210,000 | $1,676 萬 | 5.4% | +45,000+27.3% | 加碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 125,000 | $1,618 萬 | 5.2% | +25,000+25.0% | 加碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 285,000 | $1,559 萬 | 5.0% | +10,000+3.6% | 加碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 300,000 | $1,507 萬 | 4.8% | +220,000+275.0% | 加碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 1,300,000 | $1,370 萬 | 4.4% | +700,000+116.7% | 加碼 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 825,000 | $1,255 萬 | 4.0% | +575,000+230.0% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 625,000 | $1,094 萬 | 3.5% | +325,000+108.3% | 加碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 300,000 | $1,091 萬 | 3.5% | 00.0% | 不變 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 200,000 | $936.2 萬 | 3.0% | +135,000+207.7% | 加碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 60,000 | $896.7 萬 | 2.9% | +32,500+118.2% | 加碼 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 200,000 | $856.0 萬 | 2.8% | +87,615+78.0% | 加碼 | 歷史 |
| SVRASavara Inc | COM | 1,600,000 | $796.8 萬 | 2.6% | +850,000+113.3% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 130,000 | $764.1 萬 | 2.5% | +130,000 | 新進 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM | 6,000,000 | $714.0 萬 | 2.3% | +4,400,000+275.0% | 加碼 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 72,761 | $690.2 萬 | 2.2% | +72,761 | 新進 | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 225,000 | $665.3 萬 | 2.1% | +15,000+7.1% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 95,000 | $648.9 萬 | 2.1% | +25,000+35.7% | 加碼 | 歷史 |
| CABACabaletta Bio, Inc. | COM | 375,000 | $639.8 萬 | 2.1% | +225,000+150.0% | 加碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 73,002 | $598.6 萬 | 1.9% | +73,002 | 新進 | 歷史 |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 125,000 | $541.6 萬 | 1.7% | +125,000 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 175,000 | $541.1 萬 | 1.7% | +50,000+40.0% | 加碼 | 歷史 |
| REPLReplimune Group, Inc. | COM | 650,000 | $531.0 萬 | 1.7% | +250,000+62.5% | 加碼 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 485,000 | $515.1 萬 | 1.7% | +99,759+25.9% | 加碼 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 225,000 | $416.0 萬 | 1.3% | +175,000+350.0% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 150,000 | $406.9 萬 | 1.3% | +150,000 | 新進 | 歷史 |
| TNYATenaya Therapeutics, Inc. | COM | 775,000 | $405.3 萬 | 1.3% | +775,000 | 新進 | 歷史 |
| IMVTImmunovant, Inc. | COM | 125,000 | $403.9 萬 | 1.3% | +125,000 | 新進 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 100,000 | $379.3 萬 | 1.2% | +100,000 | 新進 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 150,000 | $357.0 萬 | 1.1% | +150,000 | 新進 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 200,000 | $339.0 萬 | 1.1% | +200,000 | 新進 | 歷史 |
| CGONCG Oncology, Inc. | COM | 75,000 | $329.3 萬 | 1.1% | +75,000 | 新進 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 75,000 | $321.4 萬 | 1.0% | −75,000−50.0% | 減碼 | 歷史 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | CL A ORD SHS | 300,000 | $312.0 萬 | 1.0% | +300,000 | 新進 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 450,000 | $302.4 萬 | 1.0% | +255,000+130.8% | 加碼 | 歷史 |
| AQSTAquestive Therapeutics, Inc. | COM | 702,941 | $299.5 萬 | 1.0% | +702,941 | 新進 | 歷史 |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 176,513 | $277.7 萬 | 0.9% | −48,487−21.5% | 減碼 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 950,000 | $272.6 萬 | 0.9% | −1,150,000−54.8% | 減碼 | 歷史 |
| GERNGeron Corp | COM | 800,000 | $264.0 萬 | 0.8% | +800,000 | 新進 | 歷史 |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 285,000 | $257.6 萬 | 0.8% | +150,000+111.1% | 加碼 | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 250,000 | $254.5 萬 | 0.8% | +250,000 | 新進 | 歷史 |
| RGNXREGENXBIO Inc. | COM | 120,000 | $252.8 萬 | 0.8% | +120,000 | 新進 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 14,000 | $249.1 萬 | 0.8% | −36,000−72.0% | 減碼 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 200,000 | $237.2 萬 | 0.8% | +69,964+53.8% | 加碼 | 歷史 |
| NTRANatera, Inc. | COM | 25,000 | $228.7 萬 | 0.7% | −10,000−28.6% | 減碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 200,000 | $226.4 萬 | 0.7% | +200,000 | 新進 | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 56,941 | $223.4 萬 | 0.7% | +56,941 | 新進 | 歷史 |
| RVNCRevance Therapeutics, Inc. | COM | 450,000 | $221.4 萬 | 0.7% | +75,000+20.0% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 75,000 | $217.0 萬 | 0.7% | −50,000−40.0% | 減碼 | 歷史 |
| EYPTEyePoint, Inc. | COM NEW | 90,000 | $186.0 萬 | 0.6% | −75,000−45.5% | 減碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 6,500 | $173.6 萬 | 0.6% | −8,500−56.7% | 減碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 40,000 | $165.1 萬 | 0.5% | −19,250−32.5% | 減碼 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 115,000 | $161.9 萬 | 0.5% | −220,000−65.7% | 減碼 | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 210,603 | $159.8 萬 | 0.5% | +210,603 | 新進 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 20,000 | $140.2 萬 | 0.5% | +10,000+100.0% | 加碼 | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 600,000 | $130.8 萬 | 0.4% | +600,000 | 新進 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 250,000 | $128.3 萬 | 0.4% | +250,000 | 新進 | 歷史 |
| NGNENeurogene Inc. | COM | 25,000 | $127.3 萬 | 0.4% | +25,000 | 新進 | 歷史 |
| SGMTSagimet Biosciences Inc. | COM SER A | 225,000 | $122.0 萬 | 0.4% | +225,000 | 新進 | 歷史 |
| ATYRaTYR PHARMA INC | COM NEW | 600,000 | $117.0 萬 | 0.4% | +600,000 | 新進 | 歷史 |
| PMVPPMV Pharmaceuticals, Inc. | COM | 675,000 | $114.8 萬 | 0.4% | −50,000−6.9% | 減碼 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 35,000 | $100.1 萬 | 0.3% | +35,000 | 新進 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 20,000 | $93.4 萬 | 0.3% | +20,000 | 新進 | 歷史 |
| QUREuniQure N.V. | SHS | 165,000 | $85.8 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ANTXAN2 Therapeutics, Inc. | COM | 219,331 | $71.3 萬 | 0.2% | +219,331 | 新進 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 25,000 | $68.8 萬 | 0.2% | +25,000 | 新進 | 歷史 |
選擇權（7 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $2,372 萬 | – |
| VKTXViking Therapeutics, Inc. | COM | – | $656.0 萬 |
| CYTKCytokinetics Inc | COM NEW | – | $525.8 萬 |
| IMVTImmunovant, Inc. | COM | – | $484.6 萬 |
| ACADAcadia Pharmaceuticals Inc | COM | – | $369.8 萬 |
| ITCIIntra-Cellular Therapies, Inc. | COM | – | $346.0 萬 |
| RAPTRAPT Therapeutics, Inc. | COM | – | $269.4 萬 |
2023 年第 4 季之後清倉（7 檔）
2023 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 4 季股數 | 2023 年第 4 季市值 | 2023 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| AMAMAmbrx Biopharma, Inc. | COM | 475,000 | $676.4 萬 | 3.9% | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 15,000 | $570.6 萬 | 3.3% | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 20,000 | $251.9 萬 | 1.5% | 歷史 |
| CBAYCymaBay Therapeutics, Inc. | COM | 90,000 | $212.6 萬 | 1.2% | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 35,000 | $133.0 萬 | 0.8% | 歷史 |
| BLUEbluebird bio, Inc. | COM | 465,000 | $64.2 萬 | 0.4% | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 30,000 | $59.6 萬 | 0.3% | 歷史 |